Tired of a fragmented omnichannel strategy that falls short of its promise? Join our free webinar on Oct 28 & 29 to get the ...

Boehringer Ingelheim’s Hernexeos (zongertinib) has been granted accelerated approval by the US Food and Drug Administration ...

I recently discussed this subject with Aidan Metzinger, Senior Director, Pfizer Marketing Excellence & Academy, who agrees: ...

The NHS has announced that it will fast-track patients with advanced head and neck cancers in England into a clinical trial ...

Medscape Cardiology | theheart.org is proud to be at the forefront of the Heart Failure Society of America (HFSA) Annual ...

Empathy is a core capability, regardless of function – our ability to connect with others and understand how information is ...

The US Food and Drug Administration (FDA) has approved Celltrion’s intravenous (IV) formulation of Avtozma (tocilizumab-anoh) ...

The US Food and Drug Administration (FDA) has granted accelerated approval to Jazz Pharmaceuticals’ Modeyso (dordaviprone) as ...

This year’s ASCO® meeting spotlighted a bold shift in oncology: the possibility of curing metastatic disease. A new trial ...

Botanical drugs are stepping into the space between traditional remedies and modern pharmaceuticals. These are not ...

In a crowded oncology market, strategy-led storytelling, analytics-driven design, and sustainability-centered innovation are ...

The US Food and Drug Administration (FDA) has approved PTC Therapeutics’ Sephience (sepiapterin) to treat the rare metabolic ...